These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2529016)

  • 21. High and concentration-proportional accumulation of [3H]-nitrendipine by intact cardiac tissue.
    Lüllmann H; Mohr K
    Br J Pharmacol; 1987 Mar; 90(3):567-74. PubMed ID: 3567462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle.
    Morel N; Godfraind T
    J Pharmacol Exp Ther; 1987 Nov; 243(2):711-5. PubMed ID: 2824756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
    Zheng W; Rampe D; Triggle DJ
    Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine.
    Cook NS; Weir SW; Danzeisen MC
    Br J Pharmacol; 1988 Nov; 95(3):741-52. PubMed ID: 2974739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine.
    Morel N; Godfraind T
    Br J Pharmacol; 1991 Feb; 102(2):467-77. PubMed ID: 1826619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists.
    Eltze M; Boer R; Sanders KH; Boss H; Ulrich WR; Flockerzi D
    Chirality; 1990; 2(4):233-40. PubMed ID: 1964575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interference of sodium with [3H]-nitrendipine binding to cardiac membranes.
    Schwartz J; Velly J
    Br J Pharmacol; 1985 Feb; 84(2):511-5. PubMed ID: 3156649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes.
    Matsuo M; Koibuchi Y; Tomoi M; Ono T; Shibayama F; Ohtsuka M
    Arzneimittelforschung; 1989 May; 39(5):576-9. PubMed ID: 2757673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of platelet activating factor on contractile force and 45Ca fluxes in guinea-pig isolated atria.
    Diez J; Delpón E; Tamargo J
    Br J Pharmacol; 1990 Jun; 100(2):305-11. PubMed ID: 2379035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depolarization of chick myotubes triggers the appearance of (+)-[3H]PN 200-110-binding sites.
    Pauwels PJ; Van Assouw HP; Leysen JE
    Mol Pharmacol; 1987 Dec; 32(6):785-91. PubMed ID: 2826992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
    Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
    J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative binding of two closely related dihydropyridines (isradipine and darodipine) to serum proteins and erythrocytes.
    Pinquier JL; Urien S; Lemaire M; Chaumet-Riffaud P; Tillement JP
    Pharmacology; 1988; 36(5):305-12. PubMed ID: 2457222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dihydropyridines on calcium channels in isolated smooth muscle cells from rat vena cava.
    Mironneau J; Yamamoto T; Sayet I; Arnaudeau S; Rakotoarisoa L; Mironneau C
    Br J Pharmacol; 1992 Feb; 105(2):321-8. PubMed ID: 1373097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (-)-[3H] desmethoxyverapamil labels multiple calcium channel modulator receptors in brain and skeletal muscle membranes: differentiation by temperature and dihydropyridines.
    Reynolds IJ; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1986 Jun; 237(3):731-8. PubMed ID: 3012067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of histamine H1- and H2-receptors in guinea-pig left atrial membranes by [3H]-mepyramine and [3H]-tiotidine binding.
    Hattori Y; Endou M; Gando S; Kanno M
    Br J Pharmacol; 1991 Jun; 103(2):1573-9. PubMed ID: 1909203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle.
    Feron O; Wibo M; Christen MO; Godfraind T
    Br J Pharmacol; 1992 Feb; 105(2):480-4. PubMed ID: 1313732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.